Friday, January 29, 2010

NIDA Stifles Cannabis Research - NORML

Paul Armentano, Deputy Director of NORML reports that NIDA has admitted that it discourages Medicinal cannabis research. Well, surprise surprise NIDA...I think the majority of us were already aware of your policy towards marijuana and research into medicinal use. After all, isn't it a part of the Czar's Job Description that he/she must actively attempt to discredit any valid medicinal use for cannabis?


NIDA spokeswoman Shirley Simson told the Times: "As the National Institute on Drug Abuse, our focus is primarily on the negative consequences of marijuana use. We generally do not fund research focused on the potential beneficial medical effects of marijuana."
NIDA presently oversees an estimated 85 percent of the world's research on controlled substances.
Commenting on NIDA's admission NORML Deputy Director Paul Armentano said, "NIDA has finally admitted to the world the 'Catch-22' that has been plaguing medical marijuana advocates and patients. Lawmakers demand clinical research regarding the safety and efficacy of medical cannabis, but the agency in charge of such research denies these studies from ever taking place. It's tragic that these public officials have let political ideology, not science, determine American's health decisions."